Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Beroterkib by Taiho Pharmaceutical for Melanoma: Likelihood of Approval
Beroterkib is under clinical development by Taiho Pharmaceutical and currently in Phase II for Melanoma. According to GlobalData, Phase II...
Data Insights
Beroterkib by Taiho Pharmaceutical for Solid Tumor: Likelihood of Approval
Beroterkib is under clinical development by Taiho Pharmaceutical and currently in Phase II for Solid Tumor. According to GlobalData, Phase...